Abstract
Cholestyramine is an effective drug for the reduction of plasma cholesterol because of its ability to sequester intestinal bile acids. Since metabolic alterations, including diminished intestinal absorption of vitamin D and osteomalacia have been reported with long-term use of this resin, the influence of cholestyramine on dietary balance of four mineral elements has been investigated. Wistar-strain rats were fed either a 2% cholestyramine or control diet for one month. Dietary intakes and fecal and urinary excretions of calcium, magnesium, iron, and zinc were determined using atomic absorption spectrophotometry during three, 3-day balance periods. Cholestyramine-fed rats had a net negative balance for calcium and a lower net positive balance for magnesium, iron, and zinc than the controls. Other effects of cholestyramine were an increased urinary excretion of calcium and magnesium, a decreased urinary zinc, and an alkalinization of urine. Blood and tissue cation content was unchanged except for a rèduction in serum magnesium with resin feeding. Alterations in calcium, magnesium, and zinc metabolism might be explained by inadequate vitamin D absorption from the intestine followed by an increased secretion of parathyroid hormone. A diminished iron absorption due to resin binding could account for the reported disturbance in iron balance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hunninghake DC, Probstfield JL: Drug treatment of hyperlipoproteinemia in hyperlipidemia:In Hyperlipidemia: Diagnosis and Therapy. BM Rifkind, RI Levy (eds). New York, Grune and Stratton, 1977, pp 337–362
Heaton KW, Lever JV, Barnard RE: Osteomalacia associated with cholestyramine therapy for post-ileectomy diarrhea. Gastroenterology 62:642–646, 1972
Whiteside CH, Harkins RW, Fluckiger HB, Sarett HP: Utilization of fat soluble vitamins by rats and chicks fed cholestyramine, a bile acid sequestrant. Am J Clin Nutr 16:309–314, 1966
Thompson WG, Thompson GR: Effect of cholestyramine on the absorption of vitamin D3 and calcium. Gut 10:717–722, 1969
Hashim SA, Van Itallie TB: Cholestyramine resin therapy for hypercholesterimia. JAMA 192:289–293, 1965
Runeberg L, Miettinen TA, Nikkila EA: Effect of cholestyramine on mineral excretion in man. Acta Medi Scand 192:71–76, 1972
Coronato A, Glass GBJ: Depression of the intestinal uptake of radio-vitamin B12 by cholestyramine. Proc Soc Exp Biol Med 142:1341–1344, 1973
Thomas FB, McMullogh FS, Greenberger NJ: Inhibition of the intestinal absorption of inorganic and hemoglobin iron by cholestyramine. J Lab Clin Med 78:70–80, 1971
Cassidy MM, Lightfoot FG, Grau L, Roy T, Story J, Kritchevsky D, Vahouny G: Effect of bile salt-binding resins on the morphology of rat jejunum and colon: A scanning electron microscopy study. Dig Dis Sci 25:504–512, 1980
Cassidy MM, Lightfoot FG, Vahouny GV: Morphological aspects of dietary fibers in the intestine. Adv Lipid Res 19:203–229, 1982
Asano T, Pollard M, Madsen D: Effects of cholestyramine on 1,2-dimethylhydrazine-induced enteric carcinoma in germfree rats. Proc Soc Exp Biol Med 150:780–785, 1975
Vahouny GV, Roy T, Gallo L, Story JA, Kritchevsky D, Cassidy MM, Grund B, Treadwell C: Dietary fiber and lymphatic absorption and cholesterol in the rat. Am J Clin Nutr 31:S208–210, 1978
Analytical Methods Committee: Methods for the destruction of organic matter. Analyst 85:643–654, 1960
Van Loon JC: Analytical Atomic Absorption Spectroscopy: Selected Methods. Academic Press, New York, 1980, p. 189
Watkins DW, Cassidy MM, Khalafi R, Vahouny GV: Calcium and zinc balances in rats chronically fed the bile-salt sequestrant cholestyramine (Questran). Fed Proc 42:819, 1983 (abstract)
Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics, 6th ed. Macmillan, New York, 843 pp
Hanna S: Influence of large doses of vitamin D on magnesium metabolism in rats. Metabolism 10:735–743, 1961
Becker WM, Hoekstra WG: Effect of vitamin D on65Zn absorption, distribution and turnover in rats. J Nutr 90:301–309, 1966
Antoniou LD, Shalhoub RJ, Elliot S: Zinc tolerance tests in chronic uremia. Clin Nephrol 16:181–187, 1981
Watkins DW, Antoniou LD, Shalhoub RJ: Urinary zinc in relation to other cations and flow during volume expansions and intervenious chlorothiazide. Can J Physiol Pharmacol 59:562–566, 1981
Lemann J Jr, Litzow JR, Lennon EJ: Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J Clin Invest 46:1318–1328, 1967
Muldowney FP, Freaney R, McGeeney D: Renal tubular acidosis and aminoaciduria in osteomalacia of dietary or intestinal origin. Q J Med 37:517–539, 1968
Nordin BEC: The effect of intravenous parathyroid extract on urinary pH, bicarbonate and electrolyte excretion. Clin Sci 19:311–319, 1960
Sutton RAL: Plasma magnesium concentration in primary hyperparathyroidism. Br Med J 1:529–533, 1970
Sutton RAL: Disorders of renal calcium excretion. Kidney Int 23:665–673, 1983
Dirks JH: The kidney and magnesium regulation. Kidney Int 23:771–777, 1983
Author information
Authors and Affiliations
Additional information
Supported by USDA grants 82CRCR 1071 and 82CRCR 1001.
Rights and permissions
About this article
Cite this article
Watkins, D.W., Khalafi, R., Cassidy, M.M. et al. Alterations in calcium, magnesium, iron, and zinc metabolism by dietary cholestyramine. Digest Dis Sci 30, 477–482 (1985). https://doi.org/10.1007/BF01318182
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01318182